SaaS Metrics
The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
ASCCP Management Guidelines
American Society for Colposcopy and Cervical Pathology Inc
View Origin LinkProduct Positioning & Context
Related Ecosystem & Alternatives
Discover adjacent products, open-source repositories, and developer tools sharing similar technical architecture.
Deep-Dive FAQs
What is ASCCP Management Guidelines?
ASCCP Management Guidelines is a digital product or tool described as: American Society for Colposcopy and Cervical Pathology Inc
Where did ASCCP Management Guidelines originate?
Data for ASCCP Management Guidelines was aggregated directly from the Apple App Store community ecosystem, representing raw developer and early-adopter sentiment.
When was ASCCP Management Guidelines publicly launched?
The initial public indexing or launch date for ASCCP Management Guidelines within our tracked developer communities was recorded on June 5, 2020.
How popular is ASCCP Management Guidelines?
ASCCP Management Guidelines has achieved measurable traction, logging over 8,470 reviews and facilitating 5 recorded discussions or engagements.
Which technical categories define ASCCP Management Guidelines?
Based on metadata extraction, ASCCP Management Guidelines is categorized under topics such as: Medical.
What are some commercial alternatives to ASCCP Management Guidelines?
Our semantic intelligence engine identifies potential commercial alternatives in the SaaS space, such as >=PlayingFild, which offers overlapping value propositions.
How does the creator describe ASCCP Management Guidelines?
The original author or development team describes the product as follows: "The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy ..."
Community Voice & Feedback
Does not generate results and is a waste of money- better stick with the flow charts
On my iPhone, when I select the hpv test type, the app jumps down to previous cytology, skipping current cytology. If you don’t recognize that, you’ll just select previous cytology as if it’s the current cytology and leave current cytology blank, resulting in the wrong management plan. I hope you can fix this bug.
The old app was worth the money. This one isn’t.
The new update is not user friendly like the old one. I could have saved the $15 and bought lunch and just used online sources faster and easier than this update.
Not as intuitive as previous app. I was a little frustrated to purchase the previous app that worked well but became unsupported and had to repurchase this app that is challenging to use. I haven’t figured out how to get it to navigate to the recommendation page
Great for pap advice
This new version is not intuitive at all.
Helps with management decisions, quick and easy to use at work.
For multiple scenarios it just loops back to the beginning rather than providing a recommendation.
This is a great app, very handy and reliable, and I use it daily in clinic. I love that it shows immediate and future progression to CIN-3. Helps patients understand better.
This is extreme frustrating - the recommendations in the application version no longer match the web-based version (ie have not been kept up to date)!! This has led to inadvertent mismanagement . And this is a paid application too!
I updated the app now I am not able to see all of the options in the drop down menu. My last selection option is AGC… how can I get the full use of the app???
This app is difficult to use and not nearly as clear as old app
New update is giving different result despite only supposedly adding dual staining info it now gives different recommendations than prior when no dual staining info is available.
This app is garbage. It doesn’t allow you to advance through the screens when you enter in certain info (if someone is HPV other positive with NILM cytology.) the flow charts should also be more easy to access. It’s definitely an insult to have to pay 10$ for this.
Discovery Source
Apple App Store Aggregated via automated community intelligence tracking.
Tech Stack Dependencies
No direct open-source NPM package mentions detected in the product documentation.
Media Tractions & Mentions
No mainstream media stories specifically mentioning this product name have been intercepted yet.
Deep Research & Science
No direct peer-reviewed scientific literature matched with this product's architecture.